Clopidogrel and Erysipelas - a phase IV clinical study of FDA data

Summary:

Erysipelas is reported as a side effect among people who take Clopidogrel (clopidogrel), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Sertraline, and have High blood cholesterol.

The phase IV clinical study analyzes which people have Erysipelas when taking Clopidogrel. It is created by eHealthMe based on reports of 91,038 people who have side effects when taking Clopidogrel from the FDA, and is updated regularly.

What is Clopidogrel?

Clopidogrel has active ingredients of clopidogrel. It is often used in blood clots. eHealthMe is studying from 92,160 Clopidogrel users. Check the latest studies of Clopidogrel.

What is Erysipelas?

Erysipelas (bacterial skin infection) is found to be associated with 451 drugs and 645 conditions by eHealthMe. Check the latest studies of Erysipelas.

On Jul, 25, 2026

91,038 people reported to have side effects when taking Clopidogrel.
Among them, 42 people (0.05%) have Erysipelas.

Among these 42 people:

How long have people been on Clopidogrel when they have Erysipelas? *

What is the gender of people who have Erysipelas when taking Clopidogrel? *

female: 61.54 %
male: 38.46 %

What is the age of people who have Erysipelas when taking Clopidogrel? *

What are other drugs people take besides Clopidogrel? *

Diclofenac: 15 people, 35.71%
Sertraline: 15 people, 35.71%
Acetylsalicylic Acid: 14 people, 33.33%
Theophylline: 14 people, 33.33%
Spiriva: 12 people, 28.57%
Vitamin D: 9 people, 21.43%
Aspirin: 6 people, 14.29%
Furosemide: 5 people, 11.90%
Amlodipine: 5 people, 11.90%
Piperacillin And Tazobactam: 5 people, 11.90%

What are other side effects people have besides Erysipelas? *

Drowsiness: 18 people, 42.86%
Acute Myocardial Infarction (acute heart attack): 17 people, 40.48%
Urinary Tract Infection: 17 people, 40.48%
Pain: 16 people, 38.10%
Acute Respiratory Failure: 16 people, 38.10%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 16 people, 38.10%
Hypercapnia (too much smoke): 16 people, 38.10%
Joint Pain: 16 people, 38.10%
Lung Disorder (lung disease): 15 people, 35.71%
Back Pain: 15 people, 35.71%

What are the existing conditions these people have? *

High Blood Cholesterol: 21 people, 50.00%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 18 people, 42.86%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 17 people, 40.48%
Pain: 16 people, 38.10%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 15 people, 35.71%
Gastritis (inflammation of stomach): 15 people, 35.71%
Rickets (softening of bones): 15 people, 35.71%
Restless Leg Syndrome (a powerful urge to move your legs): 15 people, 35.71%
Depression: 15 people, 35.71%
Osteoporosis (bones weak and more likely to break): 15 people, 35.71%

* Approximation only. Some reports may have incomplete information.

Do you take Clopidogrel and have Erysipelas?

- Check whether Erysipelas is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Clopidogrel:

Clopidogrel (92,160 reports)

Erysipelas treatments and more:

Erysipelas (8,077 reports)

Browse all side effects of Clopidogrel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Erysipelas:

Erysipelas (451 drugs)

Browse all the conditions that are associated with Erysipelas:

Erysipelas (645 conditions)

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on clopidogrel (the active ingredients of Clopidogrel) and Clopidogrel (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.